Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Urothelial Cancer × cabozantinib × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Carcinoma, Renal Cell 34 Carcinoma, Hepatocellular 16 Neoplasm Metastasis 13 Prostatic Neoplasms 12 Neoplasms 8 Neuroendocrine Tumors 6 Carcinoma, Non-Small-Cell Lung 6 Brain Neoplasms 6 Kidney Neoplasms 5 Breast Neoplasms 5 Sarcoma, Ewing 4 Sarcoma 4 Recurrence 4 Pancreatic Neoplasms 4 Osteosarcoma 4 Multiple Myeloma 4 Clear-cell metastatic renal cell carcinoma 4 Carcinoma, Transitional Cell 4 Urinary Bladder Neoplasms 3 Lung Neoplasms 3 Colorectal Neoplasms 3 Adenocarcinoma 3 Uterine Cervical Neoplasms 2 Thyroid Neoplasms 2 Thyroid Diseases 2 Neurofibroma, Plexiform 2 Melanoma 2 Liver Neoplasms 2 Leukemia, Myeloid, Acute 2 Glioblastoma 2

Interventions

niraparib 1 durvalumab 1 cabozantinib 1 Radiotherapy 1 Everolimus 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03425201 2024-12-31

NICARAGUA

Fundacion CRIS de Investigación para Vencer el Cáncer

Phase 1/2 Completed

Urothelial Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡